SL
NMRA icon

Siren LLC’s Neumora Therapeutics NMRA Stock Holding History

Siren LLC’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.6M Buy
8,497,822
+2,209,039
+35% +$5.72M 0.46% 47
2025
Q4 		$11.3M Buy
6,288,783
+1,930,500
+44% +$4.23M 0.34% 51
2025
Q3 		$7.93M Hold
4,358,283
– – 0.31% 53
2025
Q2 		$3.2M Hold
4,358,283
– – 0.17% 76
2025
Q1 		$4.36M Sell
4,358,283
-37,817
-0.9% -$64.8K 0.25% 59
2024
Q4 		$46.6M Buy
4,396,100
+1,789,529
+69% +$21.4M 2.06% 13
2024
Q3 		$34.4M Buy
+2,606,571
New +$30.4M 1.72% 19

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Siren LLC's NMRA Position: Q1 2026 in Review

Siren LLC increased its Neumora Therapeutics (NMRA) stake by 35% in Q1 2026, buying an estimated $5.72M and bringing the position to 8,497,822 shares worth $16.6M. The position accounts for 0.46% of the portfolio, ranked #47.

Siren LLC first reported a position in NMRA in Q3 2024 and has held it in 7 quarters since. The position peaked at $46.6M in Q4 2024. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • Siren LLC held 8,497,822 shares of Neumora Therapeutics worth $16.6M as of Q1 2026.
  • Siren LLC bought 2,209,039 Neumora Therapeutics shares in Q1 2026, an estimated $5.72M.
  • Neumora Therapeutics made up 0.46% of Siren LLC's portfolio in Q1 2026, its #47 holding.
  • Siren LLC first reported a position in Neumora Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Siren LLC's Neumora Therapeutics position peaked at $46.6M in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on Siren LLC's 13F filing for Q1 2026, filed 14 May 2026.